Literature DB >> 10742302

Functional role of muscarinic M(2) receptors in alpha,beta-methylene ATP induced, neurogenic contractions in guinea-pig ileum.

G W Sawyer1, G Lambrecht, F J Ehlert.   

Abstract

1. The muscarinic acetylcholine receptors mediating the contractile response elicited to endogenous acetylcholine released by the selective P2X receptor agonist alpha,beta-methylene ATP (mATP) were investigated in guinea-pig ileum. 2. mATP (0.1 - 30 microM) elicited a concentration-dependent neurogenic contractile response inhibited by tetrodotoxin (TTX) and antagonized by the non-selective muscarinic receptor antagonist N-methylscopolamine (NMS). 3. The contractile response to mATP was pertussis toxin-insensitive, irreversibly antagonized by N-(2-chloroethyl)-4-piperidinyl diphenylacetate (4-DAMP mustard), and unaffected by the muscarinic M(2)/M(4) receptor selective antagonist AF-DX 116 (1 microM). 4. When measured in the presence of histamine and isoproterenol after treatment with 4-DAMP mustard, mATP elicited a pertussis toxin-sensitive contractile response potently antagonized by AF-DX 116. 5. Collectively, our data suggest that endogenous acetylcholine released by mATP can elicit a direct contractile response through the muscarinic M(3) receptor and an indirect contractile response through the muscarinic M(2) receptor by antagonizing the relaxant effects of isoproterenol on histamine induced contraction.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10742302      PMCID: PMC1571964          DOI: 10.1038/sj.bjp.0703180

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  32 in total

1.  Differential coupling of subtypes of the muscarinic receptor to adenylate cyclase and phosphoinositide hydrolysis in the longitudinal muscle of the rat ileum.

Authors:  L M Candell; S H Yun; L L Tran; F J Ehlert
Journal:  Mol Pharmacol       Date:  1990-11       Impact factor: 4.436

2.  Differential regulation of PI hydrolysis and adenylyl cyclase by muscarinic receptor subtypes.

Authors:  E G Peralta; A Ashkenazi; J W Winslow; J Ramachandran; D J Capon
Journal:  Nature       Date:  1988-08-04       Impact factor: 49.962

3.  Effect of cholera toxin and pertussis toxin on opioid tolerance and dependence in the guinea-pig myenteric plexus.

Authors:  B Lux; R Schulz
Journal:  J Pharmacol Exp Ther       Date:  1986-06       Impact factor: 4.030

4.  Muscarinic receptors in canine colonic circular smooth muscle. II. Signal transduction pathways.

Authors:  L B Zhang; I L Buxton
Journal:  Mol Pharmacol       Date:  1991-12       Impact factor: 4.436

5.  Operational models of pharmacological agonism.

Authors:  J W Black; P Leff
Journal:  Proc R Soc Lond B Biol Sci       Date:  1983-12-22

6.  Effect of presynaptic P2 receptor stimulation on transmitter release.

Authors:  B Sperlagh; E S Vizi
Journal:  J Neurochem       Date:  1991-05       Impact factor: 5.372

7.  An operational model of pharmacological agonism: the effect of E/[A] curve shape on agonist dissociation constant estimation.

Authors:  J W Black; P Leff; N P Shankley; J Wood
Journal:  Br J Pharmacol       Date:  1985-02       Impact factor: 8.739

8.  Comparison of affinities of muscarinic antagonists to pre- and postjunctional receptors in the guinea-pig ileum.

Authors:  H Kilbinger; S Halim; G Lambrecht; W Weiler; I Wessler
Journal:  Eur J Pharmacol       Date:  1984-08-17       Impact factor: 4.432

9.  Functional uncoupling of muscarinic receptors from adenylate cyclase in rat cardiac membranes by the active component of islet-activating protein, pertussis toxin.

Authors:  H Kurose; M Ui
Journal:  J Cyclic Nucleotide Protein Phosphor Res       Date:  1983

10.  Dicyclomine discriminates between M1- and M2-muscarinic receptors in the guinea-pig ileum.

Authors:  H Kilbinger; A Stein
Journal:  Br J Pharmacol       Date:  1988-08       Impact factor: 8.739

View more
  1 in total

Review 1.  Improving the tolerability of anticholinergic agents in the treatment of overactive bladder.

Authors:  Roger Dmochowski
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.